Trinity Financial Advisors LLC Has $909,000 Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Trinity Financial Advisors LLC boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 118.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,728 shares of the biotechnology company's stock after buying an additional 938 shares during the quarter. Trinity Financial Advisors LLC's holdings in Axon Enterprise were worth $909,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise during the fourth quarter valued at about $30,000. Elequin Capital LP bought a new position in Axon Enterprise during the fourth quarter valued at about $46,000. Stonebridge Financial Group LLC bought a new position in Axon Enterprise during the fourth quarter valued at about $53,000. CoreFirst Bank & Trust bought a new position in Axon Enterprise during the fourth quarter valued at about $59,000. Finally, Global Financial Private Client LLC boosted its stake in Axon Enterprise by 11,100.0% during the first quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company's stock valued at $59,000 after buying an additional 111 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Up 0.7%

Axon Enterprise stock traded up $5.43 during mid-day trading on Friday, hitting $780.63. The company's stock had a trading volume of 358,906 shares, compared to its average volume of 719,761. The firm's 50 day moving average is $669.47 and its 200 day moving average is $621.53. The company has a market cap of $60.77 billion, a PE ratio of 201.71, a price-to-earnings-growth ratio of 5.17 and a beta of 1.29. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 52-week low of $279.02 and a 52-week high of $806.64.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same period in the prior year, the business earned $1.15 EPS. The business's revenue for the quarter was up 31.3% on a year-over-year basis. On average, analysts anticipate that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on AXON. The Goldman Sachs Group raised their target price on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Barclays increased their price target on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Finally, Bank of America increased their price target on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $699.55.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This trade represents a 0.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Joshua Isner sold 9,905 shares of the stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $738.03, for a total value of $7,310,187.15. Following the transaction, the president now directly owns 298,809 shares in the company, valued at approximately $220,530,006.27. This represents a 3.21% decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,969 shares of company stock valued at $29,909,594 in the last three months. Corporate insiders own 4.40% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.